To evaluate the relationship between IL20RA protein expression and clinicopathological parameters, subgroup analysis was carried out according to variables including age, sex, tumor site, depth of invasion, lymph node metastasis, TNM staging, tumor growth pattern, tissue grading, vascular tumor thrombus, extracolonic implantation, tumor size, ganglion invasion, pericancerous lymphatic infiltration, and histological classification (Table 1). The gene discussed is IL20RA; the disease is vascular neoplasm.